Australia Iron Deficiency Anemia Therapy Market Analysis

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Medical Devices Australia Iron Deficiency Anemia Therapy Market Market Analysis
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Australia Iron Deficiency Anemia Therapy Market Analysis

  • Medical Devices
  • Published Report
  • Aug 2021
  • Country Level
  • 350 Pages
  • No of Tables: 7
  • No of Figures: 26
Buy Now Buy Now

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of Australia iron deficiency anemia therapy market
    4. Currency and pricing
    5. LIMITATIONS
    6. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. DBMR TRIPOD DATA VALIDATION MODEL
    5. primary interviews with key opinion leaders
    6. MULTIVARIATE MODELLING
    7. Therapy LIFELINE CURVE
    8. DBMR MARKET POSITION GRID
    9. MARKET APPlication COVERAGE GRID
    10. vendor share analysis
    11. secondary sourcEs
    12. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. regulatory Framework
  6. epidemiology
  7. Summary Write Up
    1. OVERVIEW
  8. Pipeline analysis
  9. Market Overview
    1. Drivers
      1. RISING PREVALENCE OF Anemia
      2. Increasing cases of hemodialtion in pregnancy
      3. INCREASING PREVALENCE OF CHRONIC DISEASES
      4. Rising Diagnosis and evaluation of Iron-deficieny anemia (IDA)
    2. Restraint
      1. side effects associated with IDA drugs
    3. OPPORTUNITIES
      1. STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS
      2. RISING EXPENDITURE ON HEALTHCARE
    4. Challenge
      1. Stringent regulation policy
  10. COVID-19 IMPACT ON Australia Iron Deficiency Anaemia Therapy Market
    1. impact on price
    2. impact on demand
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS of Government and MANUFACTURERS
    5. Conclusion
  11. AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET, By therapy
    1. OVERVIEW
    2. ORAL IRON THERAPY
      1. IRON II GLYCINATE (BISGLYCINATE)
      2. FERRIC MALTOL
      3. IRON SUCROSE
      4. FERROUS FUMARATE
      5. IRON POLYMALTOSE
      6. OTHERS
    3. Parenteral iron therapy
      1. FERRIC DERISOMALTOSE
      2. FERRIC CARBOXYMALTOSE
      3. IRON SUCROSE
      4. IRON DEXTRAN
      5. FERROUS FUMARATE
      6. IRON DEXTRAN
      7. FERROUS FUMARATE
      8. FERRIC CITRATE
      9. IRON ISOMALTOSIDE
      10. OTHERS
  12. AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET, By therapy area
    1. OVERVIEW
    2. OBSTETRICS AND GYNECOLOGY
    3. RENAL
      1. DIALYSIS
      2. NON-DIALYSIS
    4. CONGESTIVE HEART FAILURE (CHF)
    5. INFLAMMATORY BOWEL DISEASE
    6. ONCOLOGY
    7. OTHERS
  13. Australia iron deficiency anemia therapy market, By population
    1. overview
    2. adults
    3. pediatric
  14. Australia iron deficiency anemia therapy market: COMPANY landscape
    1. company share analysis: Australia
  15. swot analysis
  16. company profile
    1. SANOFI
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Product Portfolio
      4. RECENT DEVELOPMENTs
    2. pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    3. MERCK KGAA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    4. VIFOR PHARMA MANAGEMENT LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. GLAXOSMITHKLINE PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    6. AFT PHARMACEUTICALS
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. ASPEN PHARMACARE AUSTRALIA PTY LTD
      1. OMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    8. AUSTRALIAN NATURALCARE
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. BLACKMORES
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. FRESENIUS KABI Ag
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. Product Portfolio
      4. Recent Development
    11. PHARMACARE LABORATORIES AUSTRALIA.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. PHARMACOSMOS A/S
      1. COMPANY SNAPSHOT
      2. Product Portfolio
      3. Recent Development
    13. SHIELD THERAPEUTICS
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. THORNE
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  17. questionnaire
  18. related reports

List of Table

TABLE 1 IRON-DEFICIENCY ANEMIA THERAPY Market, pipeline analysis

TABLE 2 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET, By therapy, 2019-2028 (USD million)

TABLE 3 Australia Oral Iron therapy in Iron deficiency Anemia therapy Market, By therapy, 2019-2028 (USD Million)

TABLE 4 Australia Parenteral Iron therapy in Iron deficiency Anemia therapy Market, By therapy, 2019-2028 (USD Million)

TABLE 5 Australia Iron deficiency Anemia therapy Market, By therapy Area, 2019-2028 (USD Million)

TABLE 6 Australia Renal in Iron deficiency Anemia therapy Market, By therapy Area, 2019-2028 (USD Million)

TABLE 7 Australia Iron deficiency Anemia therapy Market, By Population, 2019-2028 (USD Million)

List of Figure

FIGURE 1 Australia iron deficiency anemia therapy market: segmentation

FIGURE 2 Australia iron deficiency anemia therapy market: data triangulation

FIGURE 3 Australia iron deficiency anemia therapy market: DROC ANALYSIS

FIGURE 4 Australia iron deficiency anemia therapy market: country VS regional MARKET ANALYSIS

FIGURE 5 Australia iron deficiency anemia therapy market: COMPANY RESEARCH ANALYSIS

FIGURE 6 Australia iron deficiency anemia therapy market: INTERVIEW DEMOGRAPHICS

FIGURE 7 Australia iron deficiency anemia therapy market: DBMR MARKET POSITION GRID

FIGURE 8 Australia iron deficiency anemia therapy market: MARKET application COVERAGE GRID

FIGURE 9 Australia iron deficiency anemia therapy market: vendor share analysis

FIGURE 10 Australia iron deficiency anemia therapy market: SEGMENTATION

FIGURE 11 high prevalence of anemia is expected to drive the Australia iron deficiency anemia therapy market in the forecast period of 2021 to 2028

FIGURE 12 oral iron therapy segment is expected to account for the largest share of the Australia iron deficiency anemia therapy market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINT, OPPORTUNITIES, AND CHALLENGE OF australia IRON DEFICIENCY ANEMIA THERAPY market

FIGURE 14 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy, 2020

FIGURE 15 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy, 2019-2028 (USD million)

FIGURE 16 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy, CAGR (2021-2028)

FIGURE 17 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy, LIFELINE CURVE

FIGURE 18 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy AREA, 2020

FIGURE 19 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy AREA, 2021-2028 (USD million)

FIGURE 20 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy AREA, CAGR (2021-2028)

FIGURE 21 AUSTRALIA IRON DEFICIENCY ANEMIA therapy MARKET: By therapy AREA, LIFELINE CURVE

FIGURE 22 Australia iron deficiency anemia therapy markeT: By POPULATION, 2020

FIGURE 23 Australia iron deficiency anemia therapy markeT: By POPULATION, 2019-2028 (USD million)

FIGURE 24 Australia iron deficiency anemia therapy markeT: By POPULATION, CAGR (2021-2028)

FIGURE 25 Australia iron deficiency anemia therapy markeT: By POPULATION, LIFELINE CURVE

FIGURE 26 Australia iron deficiency anemia therapy market: company share 2020 (%)

Browse Related Pages

Banner